相关实验视频

Updated: Jun 5, 2025

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells

Published on: May 17, 2019

具有ETV3::NOAC2重组的广泛皮肤不确定的树突细胞瘤 (IDCT) 通过PUVA疗法成功治疗:一个病例报告

Akshay Deshpande¹, Zbigniew Rudzki², Jaideep Bhat³

¹Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Case reports in hematology

|December 9, 2024

概括

不确定的树突细胞瘤 (IDCT) 提出了诊断方面的挑战. 本报告详细介绍了一例罕见的皮肤IDCT病例,该病例具有ETV3::NOAC2重组,并通过PUVA治疗成功治疗.

科学领域:

皮肤病理学皮肤病理学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

不确定的树突细胞瘤 (IDCT) 是一种罕见的瘤.
由于缺乏共识,IDCT带来了诊断和治疗方面的挑战.
IDCT的遗传基础尚未完全阐明.

研究的目的:

报告一种罕见的皮肤IDCT病例.
为了突出IDCT中ETV3::NOAC2重新排列的关联.
评估皮肤IDCT的PUVA治疗方法.

主要方法:

一个患有皮肤IDCT的病人的病例报告.
基因分析以确定ETV3::NOAC2重新排列.
用PUVA (psoralen加紫外线A) 治疗治疗.

主要成果:

发现了一种罕见的皮肤IDCT病例.
瘤中隐藏着ETV3::NOAC2的重组.
PUVA疗法证明了有效性,副作用最小.

结论:

ETV3::NOAC2重新排列与IDCT相关.
PUVA疗法是皮肤IDCT的可行和有效的治疗选择.
需要进一步的研究来制定IDCT的治疗指南.

更多相关视频

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.